Skip to content

Utilization of Very Low Calorie Diet in Obese General Surgery Patients

Utilization of Very Low Calorie Diet in Obese General Surgery Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03553849
Enrollment
58
Registered
2018-06-12
Start date
2018-09-24
Completion date
2020-12-31
Last updated
2021-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Keywords

Very low calorie diet, General surgery

Brief summary

The investigators are studying the use of a two-week very low calorie diet (VLCD) in obese general surgery patients in a randomized single-blinded trial. The investigators hypothesize that the VLCD will positively impact the perceived surgical difficulty, operative time, hospital length of stay and 30-day complications. Additionally, the investigators anticipate reduced perioperative blood glucose levels and a reduced need for perioperative insulin administration.

Detailed description

The investigators' objective for this project is to determine the impact of a preoperative VLCD on outcomes for patients undergoing elective general surgery. Included are patients who are obese, BMI \>30, and scheduled by a Christiana Care-employed general surgeon for elective general surgery. Eligible patients are those scheduled for elective cholecystectomy, ventral or incisional hernia, umbilical hernia, and inguinal hernia surgery. The investigators will also be determining the feasibility of introducing a preoperative VLCD for patients undergoing elective general surgery in a Community Hospital setting.

Interventions

DIETARY_SUPPLEMENTVery low calorie diet

The VLCD is a prescribed diet with well-balanced macro and micronutrients. It is intended for significant weight loss in a short period of time, is intended only for the extremely obese, and must be completed under the supervision of a trained physician.

Sponsors

Christiana Care Health Services
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Masking description

The operative surgeons will be blinded to the randomization. The patient, by nature of the study, will not be blinded.

Intervention model description

The patient will be randomized into the treatment or control arm by the research team. If they are randomized into the treatment arm, they will be prescribed with a 2-week VLCD that will begin 2 weeks prior to the scheduled elective surgery.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients who are obese, BMI \>30, and scheduled by a Christiana Care-employed general surgeon for elective general surgery. * Patients between the ages of 18 and 65. * Patients scheduled for elective cholecystectomy, ventral or incisional hernia, umbilical hernia, and inguinal hernia surgery.

Exclusion criteria

* Patients will be excluded from the study if they have any of the following: 1. Recent myocardial infarction (3-6 months). 2. History of cerebral vascular accident (stroke). 3. Diabetes mellitus with a history of severe ketoacidosis. 4. Patients on SGLT2 inhibitors (glifozins) without insulin 5. Chronic use of steroids, greater than 20mg daily. 6. Bleeding peptic ulcer (unless there is radiological evidence of healing 6 months prior to entry). 7. A psychiatric history that includes suicide attempts and anyone taking psychotropic drugs, including lithium carbonate. 8. Active thrombophlebitis (or any other condition where decreased blood volume would put the patient at risk). * In addition, patients who are pregnant are excluded. If status is unknown, a pregnancy test will be required prior to the start of the VLCD.

Design outcomes

Primary

MeasureTime frameDescription
Reduction in Post Operative Complications30-days post operativelyPulmonary, cardiac and surgical complications using data collected from inpatient and outpatient charting

Secondary

MeasureTime frameDescription
Effect on Perioperative BMI2 weeksDifference in pre operative and perioperative BMI, in kg/m\^2
Effect on blood glucose levels2 weeksDifference in pre operative and perioperative blood glucose levels
Effect on insulin administration2 weeksDifference in pre operative and perioperative insulin administration, in units
Feasibility of the Study2 weeksPatient satisfaction and compliance based on patient surveys administered prior to discharge from the hospital
Effect on operative blood lossDay of surgeryComparative operative blood loss, in milliliters, between control and intervention
Effect on surgeon perceived difficultyDay of surgeryComparative surgeon perceived difficulty between control and intervention utilizing a surgeon and procedure specific survey
Effect on operative timesDay of surgeryComparative operative times, in minutes, between control and intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026